Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 308-766-0 | CAS number: 98283-67-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 04 Jan - 22 Feb 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP - Guideline study. Due to cytotoxicity more marked with pre-incubation, of the six tested doses, only four instead of 5 doses were analysable in the second assay in tester strain TA100 (+S9) as recommended by OECD guideline 471.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- (1997)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Groupe interministeriel des produits chimiques, Paris, France
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Undecyl glucoside
- EC Number:
- 308-766-0
- EC Name:
- Undecyl glucoside
- Cas Number:
- 98283-67-1
- Molecular formula:
- (C6H10O5)nC11H24O, n - number of D-glucopyranose units
- IUPAC Name:
- (2R,3S,4S,5R)-2-(hydroxymethyl)-6-(undecyloxy)oxane-3,4,5-triol
- Test material form:
- other: solid
Constituent 1
Method
- Target gene:
- his operon
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Additional strain / cell type characteristics:
- other: TA 1535, TA 1537, TA 98 and TA 100 carry a mutation of the uvr B gene and the deep rough mutation (rfa), TA100 and TA98 contain the R-factor plasmid (pkM101). TA 102 carries the deep rough mutation (rfa) and contains the R-factor plasmid (pAQ1)
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9-mix), prepared from the livers of rats treated with Aroclor 1254.
- Test concentrations with justification for top dose:
- Preliminary toxicity test:
- 50, 150, 500, 1500, 5000 µg/plate (with and without metabolic activation)
Experiment I:
- 5, 15, 50, 150, 500, 1000 µg/plate (without metabolic activation; TA 1535, TA 1537, TA 100 and TA 102)
- 5, 15, 50, 150, 500, 1500 µg/plate (without metabolic activation, TA 98)
- 15, 50, 150, 500, 1500, 3000 µg/plate (with metabolic activation, all tester strains)
Experiment II:
- 5, 15, 50, 150, 500, 1000 µg/plate (without metabolic activation, TA 1535)
- 1.5, 5, 15, 50, 150, 500 µg/plate (without metabolic activation, TA 1537)
- 5, 15, 50, 150, 500, 750 µg/plate (without metabolic activation, TA 98, TA 100 and TA 102)
- 5, 15, 50, 150, 500, 1500 µg/plate (with metabolic activation, TA 98, TA 102 and TA 1535, pre-incubation method)
- 5, 15, 50, 150, 500, 1000 µg/plate (with metabolic activation, TA 100 and TA 1537, pre-incubation method) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: sterile water
- Justification for choice of solvent/vehicle: The vehicle was chosen due to the solubility properties of the test item.
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: -S9-mix: sodium azide (TA 1535, TA 100), 9-amino-acridine (TA 1537), 2-nitro fluorene (TA 98), mitomycin c (TA 102); +S9-mix: 2-anthramine (TA 1535, TA 1537, TA 98, TA 100), benzo[a]pyrene (TA 102)
- Remarks:
- sodium azide (1 µg/plate), 9-amino-acridine (50 µg/plate), 2-nitro fluorene (2 µg/plate), mitomycin c (0.125 µg/plate), 2-anthramine (2/1 µg/plate without/with pre-incubation), benzo[a]pyrene (2 µg/plate without/with pre-incubation)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: plate incorporation; pre-incubation (experiment II with metabolic activation)
DURATION
- Pre-incubation period: 60 minutes
NUMBER OF REPLICATIONS: 3 plates for each test concentration
DETERMINATION OF CYTOTOXICITY
- Method: In order to choose the range of doses for the test, the toxic activity of the test item was determined. The toxicity assay was carried out in all the strains to be tested under the same conditions as the mutagenicity test with and without metabolic activation but using only one plate per dose instead of 3. The plates were incubated for approximately 44 hours at ca. 37°C, and the revertants were counted. The maximum dose in the preliminary toxicity assay was the maximum dose according to OECD Guideline 471 e.g. 5000 μg/plate. Toxicity was checked by microscopic examination of the background growth. - Evaluation criteria:
- A test system is considered as mutagenic if
- a test item causing a positive response proportional to the dose for at least 3 doses with, for the highest increase, a value greater than or equal to 3 times the value for the solvent control, is considered positive in the assay (TA 1535 and TA 1537)
- a test item causing a positive response proportional to the dose for at least 3 doses with, for the highest increase, a value greater than or equal to 2 times the value for the solvent control, is considered positive in the assay (TA 98, TA 100 and TA 102)
In some borderline cases, an additional criterion to be considered is the comparison between the number of revertants induced by the test item and the laboratory historical control data. Indeed, an increase in each individual value that is above the highest value of corresponding historical control data can help supporting a conclusion such as “equivocal” or “weak” mutagen. If a test item causes a positive response during a single assay and that result cannot be reproduced in at least 1 independent assay, the initial positive result may be considered as not significant. If, in all experimental conditions examined, none of the above criteria are fulfilled, a test item is considered clearly negative and unable to induce mutations in this test system. - Statistics:
- For each replicate plating, the mean and standard deviation of the number of revertants per plate were calculated. In addition, data was analysed by means of Dunnett's method allowing the comparison of the mean value for each dose to the mean value for the corresponding solvent control.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- other: S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Exp I: -S9: 1000 µg/plate: TA1535, TA1537, TA100; 1500 µg/plate: TA98; +S9: 1500 µg/plate: TA100; 3000 µg/plate: TA1535, TA1537, TA98; Exp II: -S9: 750 µg/plate: TA100; 1000 µg/plate: TA1535; +S9: 500 µg/plate: TA1535, TA1537, TA100; 1500 µg/plate: TA98
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Exp I: -S9: 1000 µg/plate: TA102; +S9: 3000 µg/plate: TA102; Exp II: -S9: 750 µg/plate: TA102; +S9: 150 µg/plate: TA102
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Water solubility: The test item was fully soluble in the vehicle (sterile water).
- Precipitation: No precipitation was observed in the main mutagenicity assay (experiment I and II) neither in the presence nor in the absence of metabolic activation.
RANGE-FINDING/SCREENING STUDIES
Cytotoxicity of the test item was assessed in a preliminary experiment resulting in:
- an important toxicity with the presence of microcolonies at the two highest tested doses of 5000 and 1500μg/plate without metabolic activation in strains TA1535, TA1537, TA100 and TA102
- an important toxicity with the presence of microcolonies at the highest tested dose of 5000μg/plate in all strains with metabolic activation and in strain TA98 without metabolic activation
- a moderate toxicity at the tested dose of 1500μg/plate in strain TA98 without metabolic activation and in strain TA100 with metabolic activation
- a slight toxicity at the tested dose of 500μg/plate in strains TA1535 ad TA1537 without metabolic activation and at the tested dose of 1500μg/plate in strains TA1535, TA1537, TA98 and TA102 with metabolic activation.
Therefore, the maximum doses retained for the first mutagenicity assay in the absence of metabolic activation were 1000 µg/plate (TA1535, TA1537, TA100 and TA102) and 1500μg/plate (TA 98) and 3000 µg/plate in all strains in the presence of metabolic activation.
COMPARISON WITH HISTORICAL CONTROL DATA
The results were within the range of the historical control data.
ADDITIONAL INFORMATION ON CYTOTOXICITY
Cytotoxicity was recorded at 1000 µg/plate (TA 1535, TA 1537, TA 100, TA 102) and 1500 µg/plate (TA 98) in the absence of metabolic activation and at 1500 µg/plate (TA 100) and 3000 µg/plate (TA 1535, TA 1537, TA 98, TA 102) in the presence of metabolic activation (experiment I). In the second experiment cytotoxicity was present at 750 µg/plate (TA 100, TA 102) and at 1000 µg/plate /TA 1535) in the absence of metabolic activation and at 150 µg/plate (TA 102), 500 µg/plate (TA 1535, TA 1537, TA 100) and 1500 µg/plate (TA 98) in the presence of metabolic activation.
Any other information on results incl. tables
Table 1: Results of the preliminary cytotoxicity test
Toxicity Assay |
Dose in µg/plate |
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
TA 102 |
|||||
T |
P |
T |
P |
T |
P |
T |
P |
T |
P |
||
Test item without S9-mix |
0 50 150 500 1500 5000 |
- - - + +++ +++ |
- - - - - - |
- - - + +++ +++ |
- - - - - - |
- - - - ++ +++ |
- - - - - - |
- - - - +++ +++ |
- - - - - - |
- - - - +++ +++ |
- - - - - - |
Top Dose in first mutagenicity assay |
|
1000 |
1000 |
1500 |
1000 |
1000 |
|||||
Test item with S9-mix |
0 50 150 500 1500 5000 |
- - - - + +++ |
- - - - - - |
- - - - + +++ |
- - - - - - |
- - - - + +++ |
- - - - - - |
- - - - ++ +++ |
- - - - - - |
- - - - + +++ |
- - - - - - |
Top dose in first mutagenicity assay |
|
3000 |
3000 |
3000 |
3000 |
3000 |
T: toxicity (- non toxic: + slightly toxic: ++ moderately toxic: +++ strongly toxic)
P: precipitation (- absence: + slight precipitate: ++ moderate precipitate: +++ important precipitate)
Table 2: Results of mutagenicity assay (experiment I)
With or without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates ± Standard deviation) |
||||
Base-pair substitution type |
Frameshift type |
|||||
TA 100 |
TA1535 |
TA 102 |
TA98 |
TA1537 |
||
– |
0 |
93.8 ± 6.1 |
14.0 ± 2.8 |
107.7 ± 23.9 |
16.2 ± 1.9 |
6.8 ± 3.4 |
– |
5 |
85.7 ± 7.1 |
14.3 ± 3.5 |
105.3 ± 15.5 |
10.3 ± 1.2 |
6.0 ± 3.0 |
– |
15 |
97.3 ± 3.5 |
17.3 ± 5.9 |
112.7 ± 9.2 |
14.3 ± 2.1 |
4.7 ± 0.6 |
– |
50 |
95.0 ± 11.3 |
16. 7 ± 1.5 |
127.3 ± 8.1 |
15.7 ± 4.2 |
4.0 ± 1.0 |
– |
150 |
85.3 ± 6.5 |
13.0 ± 2.6 |
114.7 ± 1.2 |
10.7 ± 6.4 |
3.7 ± 3.8 |
– |
500 |
82.7 ± 29.1 |
15.3 ± 4.5 |
100.7 ± 32.9 |
12.0 ± 4.0 |
4.0 ± 2.6 |
– |
1000 |
18.7 ± 1.5 |
9.3 ± 2.1 |
50.0 ± 2.0 |
- |
** |
– |
1500 |
- |
- |
- |
4.3 ± 2.1 |
- |
Positive controls, –S9 |
Name |
NaN |
NaN |
MM-c |
2-NF |
9-AA |
Concentrations (μg/plate) |
1 |
1 |
0.125 |
2 |
50 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
624.0 ± 97.3 |
477.3 ± 258.8 |
480.0 ± 142.2 |
230.7 ± 31.9 |
450.7 ± 117.1 |
|
+ |
0 |
110.5 ± 16.1 |
12.0 ± 3.7 |
179.3 ± 27.1 |
21.7 ± 4.1 |
6.7 ± 1.9 |
+ |
15 |
102.7 ± 5.5 |
8.7 ± 2.9 |
210.0 ± 28.8 |
24.0 ± 4.0 |
6.0 ± 1.0 |
+ |
50 |
104.0 ± 5.0 |
12.3 ± 2.5 |
193.3 ± 17.5 |
19.3 ± 8.1 |
6.7 ± 3.2 |
+ |
150 |
84.3 ± 2.5 |
9.0 ± 2.0 |
155.3 ± 25.0 |
19.0 ± 5.2 |
8.0 ± 2.6 |
+ |
500 |
94.7 ± 5.7 |
7.7 ± 0.6 |
189.3 ± 12.2 |
27.0 ± 6.6 |
5.0 ± 4.6 |
+ |
1500 |
31.3 ± 4.9 |
11.0 ± 2.6 |
126.0 ± 30.0 |
24.0 ± 7.9 |
3.0 ± 2.6 |
+ |
3000 |
** |
** |
22.7 ± 6.7 |
** |
** |
Positive controls, +S9 |
Name |
2-AA |
2-AA |
BaP |
2-AA |
2-AA |
Concentrations (μg/plate) |
2 |
2 |
2 |
2 |
2 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
1738.7 ± 268.8 |
418.7 ± 66.2 |
912.0 ± 224.0 |
1888.0 ± 279.0 |
154.7 ± 24.1 |
**: not analyzable due to toxicity
NaN: sodium azide
MM-c: mitomycin c
2 -NF: 2 -nitrofluorene
9 -AA: 9 -aminoacridine
2 -AA: 2 -anthramine
BaP: benz[a]pyrene
-: concentration not assessed
Table 3: Results of mutagenicity assay (experiment II)
With or without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates ± Standard deviation) |
||||
Base-pair substitution type |
Frameshift type |
|||||
TA 100 |
TA1535 |
TA 102 |
TA98 |
TA1537 |
||
– |
0 |
114.3 ± 19.7 |
12.5 ± 3.2 |
165.3 ± 20.1 |
14.8 ± 2.0 |
5.7 ± 1.6 |
|
1.5 |
- |
- |
- |
- |
9.3 ± 2.1 |
– |
5 |
109.7 ± 10.1 |
12.0 ± 3.5 |
196.0 ± 7.2 |
18.0 ± 5.2 |
9.0 ± 2.6 |
– |
15 |
104.0 ± 6.0 |
11.0 ± 2.6 |
188.7 ± 26.6 |
14.0 ± 1.0 |
10.0 ± 5.0 |
– |
50 |
91.0 ± 8.5 |
14.3 ± 6.4 |
173.3 ± 3.1 |
12.0 ± 1.0 |
7.7 ± 3.8 |
– |
150 |
107.7 ± 12.2 |
15.3 ± 4.2 |
139.3 ± 8.1 |
14.0 ± 1.7 |
4.7 ± 0.6 |
– |
500 |
93.3 ± 11.9 |
10.3 ± 4.0 |
141.3 ± 16.0 |
15.3 ± 4.2 |
6.7 ± 0.6 |
|
750 |
65.0 ± 2.8 |
- |
95.3 ± 21.6 |
13.3 ± 0.6 |
- |
– |
1000 |
- |
8.0 ± 2.6 |
- |
- |
- |
Positive controls, –S9 |
Name |
NaN |
NaN |
MM-c |
2-NF |
9-AA |
Concentrations (μg/plate) |
1 |
1 |
0.125 |
2 |
50 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
544.0 ± 48.0 |
421.3 ± 21.2 |
490.7 ± 33.3 |
244.7 ± 36.7 |
580.0 ± 102.1 |
|
+ |
0 |
71.7 ± 5.9 |
11.2 ± 3.3 |
202.0 ± 29.4 |
20.2 ± 6.5 |
5.7 ± 1.2 |
+ |
5 |
74.0 ± 12.1 |
9.7 ± 2.1 |
178.0 ± 32.7 |
23.7 ± 7.5 |
5.7 ± 0.6 |
+ |
15 |
78.3 ± 6.7 |
10.0 ± 2.0 |
164.7 ± 9.5 |
21.3 ± 5.0 |
9.7 ± 2.3 |
+ |
50 |
81.7 ± 7.2 |
9.7 ± 1.5 |
146.0 ± 9.2 |
22.3 ± 2.5 |
8.3 ± 8.4 |
+ |
150 |
94.0 ± 6.9 |
10.3 ± 1.5 |
116.0 ± 5.3 |
18.3 ± 4.7 |
6.7 ± 3.1 |
+ |
500 |
** |
6.0 ± 2.0 |
117.3 ± 11.4 |
16.3 ± 6.7 |
2.7 ± 1.5 |
|
1000 |
** |
- |
- |
- |
** |
+ |
1500 |
- |
** |
72.0 ± 22.6 |
** |
- |
Positive controls, +S9 |
Name |
2-AA |
2-AA |
BaP |
2-AA |
2-AA |
Concentrations (μg/plate) |
1 |
1 |
2 |
1 |
1 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
1280.7 ± 287.0 |
232.7 ± 20.2 |
536.0 ± 60.4 |
1152.0 ± 180.3 |
83.3 ± 12.7 |
**: not analyzable due to toxicity
NaN: sodium azide
MM-c: mitomycin c
2 -NF: 2 -nitrofluorene
9 -AA: 9 -aminoacridine
2 -AA: 2 -anthramine
BaP: benz[a]pyrene
-: concentration not assessed
Applicant's summary and conclusion
- Conclusions:
- A bacterial gene mutation assay (Ames test) was performed with the test material according to OECD TG 471 and in compliance with GLP. The test material was considered not to be mutagenic in the presence and absence of metabolic activation in the tester strains used.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.